Nano-X Imaging ($NNOX) Korean Manufacturing and Demand Alignment Case

Investors can submit applications for the lead plaintiff role.

D. New Jersey

Court

1:26-cv-07062

Case number

03/31/2025

Class period Start

04/17/2026

Class period End

08/11/2026

Lead Plaintiff motion deadline

$NNOX investors filed a claim against Nano-X Imaging for allegedly overstating operational efficiency and product demand while hiding manufacturing costs and poor demand alignment.
After Nano-X Imaging revealed a $17.5 million impairment tied to restructuring its Korean chip manufacturing facility, $NNOX fell 24.4% on April 20, 2026.
$NNOX investors can join this case to be notified about potential recovery.
Case Details:

Between March 31, 2025 and April 17, 2026, Nano-X Imaging told investors it was making operational progress, scaling commercialization, and improving manufacturing efficiency. Executives emphasized growing demand for Nanox.ARC, a robust sales pipeline, increased deployments, and efforts to build efficient manufacturing operations.

However, during this period, investors allege Nano-X Imaging’s manufacturing operations were poorly matched to actual product demand. Nano-X Imaging allegedly failed to disclose that its Korean chip manufacturing operations were not aligned with current and expected demand, that the company was experiencing higher operating costs and cash burn, and that restructuring and impairment charges were likely because parts of its manufacturing model were unsustainable.

Then, on April 20, 2026, the company revealed a fourth-quarter net loss of $33.4 million, including a $17.5 million impairment tied to restructuring operations at its Korean facility. 

$NNOX fell 24.4%, closing at $2.155. Additional revelations followed the same day, including that Nano-X Imaging would shift toward outsourced production and that its CFO would step down effective July 31, 2026.

Based on these events, $NNOX investors filed a claim against Nano-X Imaging, alleging the company:
It overstated operating efficiency.
It misrepresented demand and manufacturing progress while costs and cash burn increased.
It caused investors to reassess Nano-X Imaging when restructuring and impairment charges emerged.
Investors argue Nano-X Imaging misled the market about manufacturing efficiency, demand alignment, and cost controls, causing losses when the truth emerged.

Case Type

US Securities Class Action

Case Status

Lead Plaintiff Submission

Alleged Offence

Misleading Statements,

Financial Misrepresentation,

Fraud,

Failure to Disclose,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

04/20/2026

Filing date

06/12/2026

Lead Plaintiff Deadline

08/11/2026

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.